Contribution of hypoxia to the development of cardiomyopathy in hamsters

Cardiovascular Research

Volumn 35, Issue 2, 1997, Pages 217-222

  Watanabe, Yoshiyuki ^a   Kusuoka, Hideo ^a   Fukuchi, Kazuki ^a   Fujiwara, Toshiyuki ^a   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; IODOPHENAZONE; NITROIMIDAZOLE DERIVATIVE; TECHNETIUM 99M;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CARDIOMYOPATHY; HAMSTER; HISTOPATHOLOGY; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RADIOISOTOPE DIAGNOSIS;

ANIMALS; ANOXIA; ANTIPYRINE; AUTORADIOGRAPHY; CARDIOMYOPATHY, DILATED; CRICETINAE; IODINE RADIOISOTOPES; MESOCRICETUS; MYOCARDIUM; NITROIMIDAZOLES; ORGANOTECHNETIUM COMPOUNDS;

EID: 0030823776     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00085-0     Document Type: Article

References (30)

1. Bajusz E, Homburger F, Baker JR. The heart muscle in muscular dystrophy with special reference to involvement of the cardiovascular system in the hereditary myopathy of the hamster. Ann NY Acad Sci 1966;138:213-231.
2. Weisman HF. The role of calcium channel abnormalities in Syrian hamster cardiomyopathy. Clin Immunol Immunopathol 1993;68:170-174.
3. Gwathmey JK, Davidoff AJ. Experimental aspect of cardiomyopathy. Curr Opin Cardiol 1993;8:480-495.
4. Davidoff AJ, Gwathmey JK. Pathophysiology of cardiomyopathies. I. Animal models and humans. Curr Opin Cardiol 1994;9:357-368.
5. Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation 1982;66:342-354.
6. Geft IL, Fishbein MC, Nimomiya K, et al. Intermittent brief period of ischemia have a cumulative effect and may cause myocardial necrosis. Circulation 1982;66:1150-1153.
7. Rumsey WL, Cyr JE, Raju N, Narra RK. A novel [99m]technetium-labeled nitroheterocycle capable of identification of hypoxia in Heart. Biochem Biophys Res Commun 1993;193:1239-1246.
8. Linder KE, Chan Y-W, Cry JE, Malley MF, Nowotnik DP, Nunn AD. TcO(PnAO-1-(2-nitroimidazole))[BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction. J Med Chem 1994;37:9-17.
9. Chapman JD. Hypoxia sensitizer - implication for radiation therapy. N Engl J Med 1979;301:1429-1432.
10. Agrawal KC, Larroquette CA, Grag PK. Pharmacokinetic studies of amino acid analogues of 2-nitroimidazole, new hypoxic cell radiosensitizers. Int J Radiat Oncol Biol Phys 1984;10:1301-1305.
11. Rauth AM, McClelland RA, Michaels HB, Battistella R. The oxygen dependence of the reduction of nitroimidazoles in a radiolytic model system. Int J Radiat Oncol Biol Phys 1984;10:1323-1326.
12. Franko AJ. Misonidazole and other hypoxia markers: metabolism and applications. Int J Radiat Oncol Biol Phys 1986;12:1195-1202.
13. Fukuchi K, Kusuoka H, Watanabe Y, Fujiwara T, Nishimura T. Ischemic and reperfused myocardium detected with Tc-99m nitroimidazole. J Nucl Med 1996;37:761-766.
14. 99mTc-labeled nitroimidazole (BMS-181321), after regional ischemia and reperfusion. Circulation 1995;92:1246-1253.
15. Kusuoka H, Hashimoto K, Fukuchi K, Nishimura T. Kinetics of a putative hypoxic tissue marker, technetium-99m-labeled nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic, and stunned myocardium. J Nucl Med 1994;35:1371-1376.
16. Ng CK, Sinusas AJ, Zaret BL, Soufer R. Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS181321) as a tracer of myocardial hypoxia. Circulation 1995;92:1261-1268.
17. Martin GV, Cerqueira MD, Caldwell JH, Rasey JS, Embree L, Krohn KA. Fluoromisonidazole. A metabolic marker of myocyte hypoxia. Circ Res 1990;67:240-244.
18. Nakajo M, Shimabukuro K, Yoshimura H, et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 1986;27:84-89.
19. Yamane Y, Ishida N, Kagaya Y, et al. Quantitative double-tracer autoradiography with tritium and carbon-14 using imaging plates: application to myocardial metabolic studies in rats. J Nucl Med 1995;36:518-524.
20. Bajusz E, Baker RJ, Nixon WC, Homburger F. Spontaneous hereditary myocardial degeneration and congestive heart failure in a strain of Syrian hamsters. Ann NY Acad Sci 1969;156:105-129.
21. 131I-iodide. Int J Appl Radiat Isotopes 1979;30:365-367.
22. Bajusz E. Hereditary cardiomyopathy: a new disease model. Am Heart J 1969;77:686-696.
23. Gertz EW. Cardiomyopathic Syrian hamster: a possible model of human disease. Prog Exp Tumor Res 1972;16:242-260.
24. Eng C, Cho S, Factor SM, Sonnenblick EH, Kirk ES. Myocardial micronecrosis produced by microsphere embolization. Role of an alpha adrenergic tonic influence on the coronary microcirculation. Circ Res 1984;54:74-82.
25. Toussaint M, Duboc D, Lucet P, Pfister A, Lage CD. Congestive cardiomyopathy and spasm of coronary microvascularisation in man. Ann Pathol 1987;7:223-226.
26. Nienaber CA, Gambhir SS, Mody FV, et al. Regional myocardial blood flow and glucose utilization in symptomatic patient with hypertrophic cardiomyopathy. Circulation 1993;87:1580-1590.
27. 14C]antipyrine. Am J Physiol 1978;234:H59-H66.
28. Figulla HR, Vetterlein F, Glaubitz M, Kreuzer H. Inhomogeneous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster. Circulation 1987;76:208-216.
29. Olivetti G, Cigola E, Lagrasta C, et al. Spirapril prevents left ventricular hypertrophy, decreases myocardial damage and promotes angiogenesis in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1993;21:362-370.
30. Kagaya Y, Kanno Y, Takeyama D, et al. Effect of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. Circulation 1990;81:1353-1361.